$69 postpage LB

Here’s why Allegra Orthopaedics’ (ASX:AMT) Shares have Exploded on ASX today

  • December 04, 2020 03:59 PM AEDT
  • Team Kalkine
Here’s why Allegra Orthopaedics’ (ASX:AMT) Shares have Exploded on ASX today


  • Allegra Orthopaedics announced promising results on its Spinal Cage Device flagship innovation project.
  • The Company was testing the revised Spinal Cage design in an accredited testing facility in the US.
  • With the favourable outcomes, Allegra will now test the new Spinal Cage design in further studies.
Gold MTF non-AMP

The share price of ASX-listed medical device company Allegra Orthopaedics Limited (ASX: AMT) skyrocketed today after the Company announced positive results on its flagship innovation project, Spinal Cage Device. The AMT shares were trading at A$0.460, up by 130% (at AEDT 3:35 PM). The Company has a market capitalisation of A$20.89 million.

About Allegra Orthopaedics

Allegra Orthopaedics is working with the vision to enhance health care standards and improve the quality of life for patients. The Company has utilised its expertise in developing and commercialising medical devices to generate a new products pipeline.

Allegra is currently commercialising Sr-HT-Gahnite bone substitute and has licences the IP from The University of Sydney.

Encouraging results in Sr-HT-Gahnite Spinal Cage Device test

After the successful testing of the Spinal Cage Device, Allegra was testing the revised Spinal cage design in an accredited testing facility in the US. This test was performed to verify the effectiveness of the amended Spinal Cage design.

On 4 December 2020, the Company announced that the findings demonstrate a substantial upturn in strength when compared to the initial design.  More precisely, the compressive strength of the Spinal Cage was found to be 60kN. This is drastically higher than the human physiological load (i.e. 1.2kN) and sheep physiological load (i.e. around 3-4kN).

Besides, it is also twice the compressive strength when compared with the previous cage design and above the 95th percentile for available information on cages approved by the FDA.

These findings are accompanied by increased torsional and shear compressive strengths, including the mechanical integrity of the testing.

Significantly, a similar facility conducted dynamic compressive testing to determine the fatigue life of the Spinal Cage.

The Company stated that it passed the 5 million dynamic cycles required by the regulatory agency with no indications of failure or fracture.

Allegra Progressing with the new Spinal Cage design

With these positive findings, Allegra is now progressing with the new Spinal Cage design. The Company intends to initiate a pilot animal experiment in January 2021 in Australia.

Allegra stated that this would be a confirmatory trial to be followed by a large-scale animal study, according to the requirements of the FDA.



The website https://kalkinemedia.com/au is a service of Kalkine Media Pty. Ltd. (Kalkine Media) A.C.N. 629 651 672. The principal purpose of the content on this website is to provide factual information only and does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stock of the company (or companies) or engage in any investment activity under discussion. We are neither licensed nor qualified to provide investment advice through this platform. In providing you with the content on this website, we have not considered your objectives, financial situation or needs. You should make your own enquiries and obtain your own independent advice prior to making any financial decisions.
Some of the images that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed on this website unless stated otherwise. The images that may be used on this website are taken from various sources on the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image. The information provided on the website is in good faith, however Kalkine Media does not make any representation or warranty regarding the content, accuracy, or use of the content on the website.


We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK